LFM-A13

(2Z)-2-Cyan-N-(2,5-dibromphenyl)-3-hydroxy-2-butenamid

(2Z)-2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide

(2Z)-2-Cyano-N-(2,5-dibromophényl)-3-hydroxy-2-buténamide

(2Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide

2-Butenamide, 2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-, (2Z)-

2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide

244240-24-2

62004-35-7

a-cyano-b-hydroxy-b-methyl-N-(2,5-dibromophenyl)propenamide

LFM-A13

MFCD09878279

α-Cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide

(Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide

(Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide(LFM-A13)

(Z)-LFM-A13

2-Butenamide, 2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-

2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide

2Z-cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide

2Z-cyano-N-(2,5-dibromophenyl)3-hydroxy-2-butenamide

BTK_MOUSE

LFM-A13;2-CYANO-N-(2,5-DIBROMOPHENYL)-3-HYDROXY-2-BUTENAMIDE

Tyrosine-protein kinase BTK

α-cyano-β-hydroxy-β-methyl-N-(2, 5-dibromophenyl)propenamide